<DOC>
	<DOCNO>NCT00826774</DOCNO>
	<brief_summary>The purpose study compare three method achieve weight loss primary care medical practice . The study conduct six primary care practice . Weight management provide total 390 obese patient ( 2 component metabolic syndrome ) primary care provider , conjunction practice ' auxiliary health professional , include medical assistant .</brief_summary>
	<brief_title>Improving Management Obesity Primary Care Practice ( The Power-UP Trial )</brief_title>
	<detailed_description>Obesity , define body mass index ( BMI ) ≥ 30 kg/m2 , affect 31 % American adult . Additionally , nearly one-quarter U.S. adult meet criterion metabolic syndrome , cluster clinical sign ( i.e. , elevate waist circumference , blood pressure , glucose triglyceride , decrease HDL cholesterol ) associate increase risk cardiovascular death . Behavior modification program pharmacologic intervention obesity typically result 8 % 10 % loss initial body weight . Losses magnitude associate clinically significant improvement metabolic parameter among obese person . The availability traditional behavioral weight control program , however , limit many program base academic medical center . Furthermore , pharmacotherapy seldom cover third-party payer . Thus , concern accessibility intervention many obese individual could benefit weight loss . The purpose study improve management obesity primary care practice , obesity commonly encounter infrequently address . Three hundred ninety person 6 primary care practice within University Pennsylvania Health System randomize one three 2-year intervention : Usual Care , Brief Lifestyle Counseling , Enhanced Brief Lifestyle Counseling . After train obesity management intervention strategy , site enroll approximately 65 individual BMI 30-50 kg/m2 plus two component metabolic syndrome . Participants Usual Care condition ( N=130 ) receive educational material plus quarterly visit primary care provider ( PCP ) . Those Brief Lifestyle Counseling condition ( N=130 ) receive PCP visit , plus 26 brief counseling session auxiliary health care provider ( e.g. , medical assistant ) , on-site phone . Participants Enhanced Brief Lifestyle Counseling condition ( N=130 ) additionally receive treatment Brief Lifestyle Counseling group , plus choice adjunctive meal replacement pharmacotherapy . Two-year change weight compare across group . Participants receive Brief Lifestyle Counseling Enhanced Brief Lifestyle Counseling intervention predict achieve great weight loss receive Usual Care . A secondary hypothesis participant Enhanced Brief Lifestyle Counseling condition lose significantly weight month 24 participant Brief Lifestyle Counseling group . Secondary analysis also compare change metabolic syndrome ( individual component ) , mood , quality life , dietary intake , eat behavior , appetite , physical activity sexual function , well cost-effectiveness , among three condition . Intervention protocol study result disseminate health care provider payer .</detailed_description>
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Obesity</mesh_term>
	<mesh_term>Hypercholesterolemia</mesh_term>
	<mesh_term>Metabolic Syndrome X</mesh_term>
	<criteria>Age ≥ 21 year BMI 3050 kg/m2 weight ≤ 400 lb . At least 2 5 criterion metabolic syndrome Elevated waist circumference ( &gt; 102 cm men , &gt; 88 cm woman ) Elevated blood pressure ( ≥ 130/85 mmHg ) Impaired fast glucose ( ≥ 100 mg/dl ) Elevated triglyceride ( ≥ 150 mg/dl ) Low HDL cholesterol ( &lt; 40 men , &lt; 50 mg/dl woman ) Willing change diet , physical activity weight Willing accept randomization group Able give inform consent Patient participate PCP Persons follow condition eligible PCP approval : Diabetes mellitus Prior CVD event &gt; 6 month randomization Stable CVD peripheral vascular disease Serious medical condition likely hinder accurate measurement weight , weight loss contraindicate , would cause weight loss ( e.g. , endstage renal disease dialysis , cancer diagnosis treatment within 2 yr ) Prior plan bariatric surgery Chronic use ( least past 6 month ) medication likely cause weight gain prevent weight loss ( e.g . corticosteroid , lithium , olanzapine , risperidone , clozapine ) Unintentional weight loss within 6 month enrollment ( ≥ 5 % body weight ) Intentional weight loss within 6 month enrollment ( ≥ 5 % body weight ) Pregnant nursing within past 6 month Plans relocate area within 2 year Another member household study participant staff trial Consumes &gt; 14 alcoholic drink per week Current use illicit substance Psychiatric hospitalization last year Psychiatric condition likely impair adherence treatment ( e.g. , schizophrenia ) Blood pressure ≥ 160/100 mmHg ; patient may rescreened 1 month Principal Investigator PCP discretion</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2012</verification_date>
	<keyword>Body Weight</keyword>
	<keyword>Overweight</keyword>
	<keyword>Hypertension</keyword>
	<keyword>Hyperglycemia</keyword>
</DOC>